Ovarian reserve testing: a user's guide
R Tal, DB Seifer - American journal of obstetrics and gynecology, 2017 - Elsevier
Ovarian reserve is a complex clinical phenomenon influenced by age, genetics, and
environmental variables. Although it is challenging to predict the rate of an individual's …
environmental variables. Although it is challenging to predict the rate of an individual's …
The physiology and clinical utility of anti-Müllerian hormone in women
D Dewailly, CY Andersen, A Balen… - Human reproduction …, 2014 - academic.oup.com
BACKGROUND The measurement of circulating anti-Müllerian hormone (AMH) has been
applied to a wide array of clinical applications, mainly based on its ability to reflect the …
applied to a wide array of clinical applications, mainly based on its ability to reflect the …
ESHRE guideline: female fertility preservation
ESHRE Guideline Group on Female … - Human …, 2020 - academic.oup.com
STUDY QUESTION What is the recommended management for women and transgender
men with regards to fertility preservation (FP), based on the best available evidence in the …
men with regards to fertility preservation (FP), based on the best available evidence in the …
Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications
SL Broer, FJM Broekmans, JSE Laven… - Human reproduction …, 2014 - academic.oup.com
BACKGROUND In women, anti-Müllerian hormone (AMH) is exclusively produced by
granulosa cells of ovarian follicles during the early stages of follicle development. After an …
granulosa cells of ovarian follicles during the early stages of follicle development. After an …
Chemotherapy-induced damage to ovary: mechanisms and clinical impact
Cancer is a major public health problem around the world. Currently, about 5% of women
diagnosed with cancer are of reproductive age. These young survivors may face …
diagnosed with cancer are of reproductive age. These young survivors may face …
Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review
RA Anderson, D Cameron, F Clatot… - Human reproduction …, 2022 - academic.oup.com
BACKGROUND Female patients undergoing anticancer treatment are at elevated risk of
adverse ovarian outcomes including infertility and premature ovarian insufficiency (POI) …
adverse ovarian outcomes including infertility and premature ovarian insufficiency (POI) …
Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults
Preservation of gonadal function is an important priority for the long-term health of cancer
survivors of both sexes and all ages at treatment. Loss of opportunity for fertility is a prime …
survivors of both sexes and all ages at treatment. Loss of opportunity for fertility is a prime …
Female infertility
RL Barbieri - Yen and Jaffe's reproductive endocrinology, 2019 - Elsevier
Infertility affects approximately 13% of women and 10% of men. The major causes of female
infertility are anovulation, fallopian tube disease, pelvic adhesions, endometriosis, and …
infertility are anovulation, fallopian tube disease, pelvic adhesions, endometriosis, and …
Infertility in reproductive‐age female cancer survivors
JM Levine, JF Kelvin, GP Quinn, CR Gracia - Cancer, 2015 - Wiley Online Library
Improved survival rates among reproductive‐age females diagnosed with cancer have
increased the focus on long‐term quality of life, including maintenance of the ability to …
increased the focus on long‐term quality of life, including maintenance of the ability to …
[HTML][HTML] What should be done in terms of fertility preservation for patients with cancer? The French 2021 guidelines
N Rives, B Courbière, T Almont, D Kassab… - European Journal of …, 2022 - Elsevier
Aim To provide practice guidelines about fertility preservation (FP) in oncology. Methods We
selected 400 articles after a PubMed review of the literature (1987–2019) …
selected 400 articles after a PubMed review of the literature (1987–2019) …